CADL: Candel P/S multiplikatori
Candel Therapeutics miya va prostata o'smalari uchun virusli immunoterapiyaga e'tibor qaratadi hamda davlat jamg'armalari va sug'urta kompaniyalari to'lovlariga tayanadi. Kompaniyaning joriy P/S koeffitsiyenti uning kapitalizatsiyasining daromadga nisbatan bozor qiymatini aks ettiradi va ushbu ko'rsatkich 1523.70 atrofida shakllangan. Ushbu narx dinamikasi III bosqich sinovlariga o'tish va dori ishlab chiqarishda tashqi shartnomaviy ishlab chiqarish tashkilotlariga yuqori bog'liqlik bilan bog'liqdir.
Candel Therapeutics (CADL) kompaniyasi koʻrsatkichlari kesimi va tahlili
- bozor narxi va tahlilchilarning maqsadli narxlari:
- bozor kapitallashuvi haqida ma'lumot:
- balans bo'yicha xususiy kapital ma'lumotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Qarzning kapitalga nisbati Candel Therapeutics|CADL - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati candeltx.com|CADL - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Candel|CADL - Kompaniyaning uzoq muddatli majburiyatlari|Qisqa muddatli majburiyatlar miqdori Candel Therapeutics|Oraliq qoplash koeffitsiyenti candeltx.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
CADL - Sof foyda|Kutilayotgan sof foyda Candel Therapeutics|CADL - Narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori candeltx.com|CADL - PEG multiplikatori|EV/EBITDA multiplikatori Candel|CADL - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi 12 oy davomida bitta aksiya uchun foyda Candel Therapeutics|CADL - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi candeltx.com|CADL - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Candel Therapeutics
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning jamlanma tahliliyoti:Candel Therapeutics Inc., CADL
Fundamental jihatdan barqaror aktivlarni aniqlash uchun investorlar narxning savdoga nisbati (P/S) ko'rsatkichini baholaydilar, bu ko'rsatkich biznesning joriy daromadlariga nisbatan qanchalik hadda qimmat baholanganini belgilaydi. Candel Therapeutics (CADL) kompaniyasining tijorat mahsulotlari mavjud emasligi sababli, ushbu P/S tebranishlari kompaniyaning saratonga qarshi dori bozoridagi haqiqiy narx belgilash imkoniyatlaridan ko'ra, klinik sinovlarga oid spekulyativ kutishlarni aks ettiradi.
Candel Therapeutics kimlar bilan raqobatlashadi
Kapitalizatsiyaning daromadga nisbati beigene.com ONC|P/S multiplikatori HALO (Halozyme)|P/S multiplikatori Revolution Medicines Inc RVMD|AAPG - Narxning daromadga nisbati|CGON (CG Oncology Therapeutics) - Kapitalizatsiya va daromad nisbati|URGN: P/S multiplikatori|Kapitalizatsiya va daromad nisbati BCAX|PSNL (Personalis) - P/S multiplikatori|Sotuvga nisbatan narx Erasca Inc ERAS|Narxning daromadga nisbati Delcath (DCTH)|Narxning daromadga nisbati YMAB (Y-mAbs Corp)|Aura Biosciences, Inc. - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati ARAY|SLS: Kapitalizatsiyaning daromadga nisbati|Actuate Therapeutics Inc. - Kapitalizatsiyaning sotish hajmiga nisbati|CTOR: P/S multiplikatori|TuHURA Biosciences - Bozor kapitallashuvining daromadga nisbati|TARA (Protara Therapeutics) - P/S multiplikatori|Sotuvga nisbatan narx fatetherapeutics.com FATE|Narxning daromadga nisbati Aadi Bioscience Inc (WHWK)|TCRX (tscan.com) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori CSBR (Champions Oncology, Inc.)|P/S multiplikatori XBiotech Inc XBIT|CVM - Narxning daromadga nisbati|Narxning sotuvga nisbati OSTX|RADX: P/S multiplikatori|Sotuvga nisbatan narx Artiva Biotherapeutics (ARTV)|Kapitalizatsiyaning daromadga nisbati ANL|P/S multiplikatori Veru Corporation|Kapitalizatsiyaning daromadga nisbati TPST (Tempest Therapeutics)|Kapitalizatsiyaning sotish hajmiga nisbati XLO|P/S multiplikatori RENB (Renovaro)|Narx/daromad koeffitsiyenti Mural Oncology PLC (MURA)|Kairos Pharma Inc - P/S multiplikatori|OnKure Therapeutics Inc (OKUR) - Kapitalizatsiyaning daromadga nisbati|w2.cytomed.sg (GDTC) - Narxning daromadga nisbati|CRIS - Narx/daromad koeffitsiyenti|APLM (Apollomics Inc.) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Tharimmune Inc (THAR)|P/S multiplikatori ADVB|P/S multiplikatori Genprex Inc (GNPX)|P/S multiplikatori CLDI (Calidi Biotherapeutics, Inc.)|SBFM: Kapitalizatsiya va daromad nisbati|XBIO - Narxning daromadga nisbati|SLRX: Narxning daromadga nisbati|PPBT: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati American Oncology Network, Inc.|BGNE (BeiGene, Ltd.) - P/S multiplikatori|P/S multiplikatori checkpointtx.com|Narxning daromadga nisbati Elevation Oncology (ELEV)|icadmed.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori IKNA (Ikena Oncology)|NTBL - Kapitalizatsiyaning daromadga nisbati|Viracta - P/S multiplikatori|Sotuvga nisbatan narx morphosys.com|NAYA Biosciences Inc. (NAYA) - Narxning daromadga nisbati|Ascentage Pharma Group International - Bozor kapitallashuvining daromadga nisbati
